Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

<iframe
  src="https://statesidedaily.com/embed/cluster/e822d8985ee55680eed7350e81f2453704075a07"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage"></iframe>